VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $891,000 | +21.9% | 36,300 | 0.0% | 0.11% | +26.2% |
| Q2 2016 | $731,000 | -23.5% | 36,300 | 0.0% | 0.08% | -23.6% |
| Q1 2016 | $955,000 | -74.1% | 36,300 | 0.0% | 0.11% | -78.2% |
| Q4 2015 | $3,690,000 | +359.5% | 36,300 | +706.7% | 0.50% | +276.1% |
| Q3 2015 | $803,000 | -23.1% | 4,500 | -4.3% | 0.13% | -14.1% |
| Q2 2015 | $1,044,000 | +11.8% | 4,700 | 0.0% | 0.16% | +17.3% |
| Q1 2015 | $934,000 | +37.6% | 4,700 | 0.0% | 0.13% | +40.0% |
| Q4 2014 | $679,000 | +10.0% | 4,700 | 0.0% | 0.10% | +4.4% |
| Q3 2014 | $617,000 | +4.0% | 4,700 | 0.0% | 0.09% | +5.8% |
| Q2 2014 | $593,000 | -4.4% | 4,700 | 0.0% | 0.09% | +13.2% |
| Q1 2014 | $620,000 | – | 4,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |